Decitabine-based conditioning regimen is feasible and effective in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia

被引：0
|
作者：
赵小利 [1 ]
机构：
[1] Instit Hemato & Blood Dis Hosp,CAMS & PUMC
来源：
China Medical Abstracts (Internal Medicine) | 2019年 / 36卷 / 03期
关键词：
AML; Decitabine-based conditioning regimen is feasible and effective in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia;
D O I：
暂无
中图分类号：
R733.7 [白血病]; R551.3 [骨髓疾病];
学科分类号：
1002 ; 100201 ; 100214 ;
摘要：
Objective To assess the efficacy and toxicity of decitabine-based conditioning regimen in patients with myelodysplastic syndrome (MDS),acute myeloid leukemia secondary to MDS (MDS-AML) or chronic myelomonocytic leukemia (CMML). Methods From March
引用
下载
收藏
页码：183 / 184
页数：2
相关论文
共 50 条
  • [1] Decitabine/Cedazuridine in the Management of Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia in Canada
    Yun, John Paul
    Ding, Philip Q.
    Dolley, Aastha
    Cheung, Winson Y.
    CURRENT ONCOLOGY, 2023, 30 (09) : 8005 - 8018
  • [2] Role of cedazuridine/decitabine in the management of myelodysplastic syndrome and chronic myelomonocytic leukemia
    Thota, Swapna
    Oganesian, Aram
    Azab, Mohammad
    Griffiths, Elizabeth A.
    FUTURE ONCOLOGY, 2021, 17 (16) : 2077 - 2087
  • [3] Decitabine: An effective and safe treatment for myelodysplastic syndrome and acute myeloid leukemia
    Feng, Xianqi
    Chen, Xiangyun
    Nie, Shumin
    Chang, Yanyan
    Meng, Fanjun
    Zhou, Jingjing
    Mao, Chunxia
    Li, Tianlan
    Yan, Xueshen
    Huang, Junxia
    Liu, Shanshan
    Gao, Yan
    Xiao, Shuxin
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (07) : 1471 - 1476
  • [4] A dog with myelodysplastic syndrome: Chronic myelomonocytic leukemia
    Hiraoka, Hiroko
    Hisasue, Masaharu
    Nagashima, Naho
    Miyama, Takako
    Tanimoto, Takashi
    Watanabe, Malaika
    Itamoto, Kazuhito
    Mizuno, Takuya
    Inokuma, Hisashi
    Okuda, Masaru
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2007, 69 (06): : 665 - 668
  • [5] CHRONIC MYELOMONOCYTIC LEUKEMIA AS A VARIANT ON MYELODYSPLASTIC SYNDROME
    KALNBERZA, GK
    ROTSENA, AY
    BONDARE, DK
    TEILANE, IY
    GRANT, KY
    OSE, VP
    ZILE, MA
    REISKART, LV
    AMOLYNYA, AY
    LIGUTE, GK
    TERAPEVTICHESKII ARKHIV, 1988, 60 (11): : 120 - +
  • [6] Decitabine Is Effective and Safe In Patients with Chronic Myelomonocytic Leukemia.
    Jabbour, Elias
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Cornelison, A. Megan
    Kadia, Tapan
    Borthakur, Cautam
    Cortes, Jorge E.
    Garcia-Manero, Guillermo
    BLOOD, 2010, 116 (21) : 1644 - 1644
  • [7] New landscapes in the management of myelodysplastic syndromes and chronic myelomonocytic leukemia: oral decitabine
    Niscola, Pasquale
    Mazzone, Carla
    Molica, Matteo
    Fabritiis, Paolo de
    FUTURE ONCOLOGY, 2021, 17 (16) : 1973 - 1975
  • [8] On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia
    E J Feldman
    J Cortes
    D J DeAngelo
    T Holyoake
    B Simonsson
    S G O'Brien
    J Reiffers
    A R Turner
    G J Roboz
    J H Lipton
    F Maloisel
    P Colombat
    G Martinelli
    J L Nielsen
    S Petersdorf
    F Guilhot
    J Barker
    P Kirschmeier
    E Frank
    P Statkevich
    Y Zhu
    S Loechner
    A List
    Leukemia, 2008, 22 : 1707 - 1711
  • [9] On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia
    Feldman, E. J.
    Cortes, J.
    DeAngelo, D. J.
    Holyoake, T.
    Simonsson, B.
    O'Brien, S. G.
    Reiffers, J.
    Turner, A. R.
    Roboz, G. J.
    Lipton, J. H.
    Maloisel, F.
    Colombat, P.
    Martinelli, G.
    Nielsen, J. L.
    Petersdorf, S.
    Guilhot, F.
    Barker, J.
    Kirschmeier, P.
    Frank, E.
    Statkevich, P.
    Zhu, Y.
    Loechner, S.
    List, A.
    LEUKEMIA, 2008, 22 (09) : 1707 - 1711
  • [10] CHRONIC MYELOMONOCYTIC LEUKEMIA (CMMOL) PLUS THE MYELODYSPLASTIC SYNDROME
    WICKRAMANAYAKE, PD
    PALLENSCHAT, J
    DIEHL, V
    MEDIZINISCHE KLINIK, 1991, 86 (08) : 383 - 386
12345